Export

EN
FR
Warfarin
Essential medicine status
Section:
10. Medicines affecting the blood 10.2. Medicines affecting coagulation
ATC codes: B01AA03
EMLc
Indication
Cerebral ischaemic stroke due to embolic occlusion ICD11 code: 8B11.2
INN
Warfarin
Medicine type
Chemical agent
List type
Core (EML)
Complementary (EMLc)
Formulations
Oral > Solid: 5 mg (sodium salt) ; 1 mg (sodium salt) ; 2 mg (sodium salt) ; 0.5 mg (sodium salt) (EMLc)
EML status history
First added in 1977 (TRS 615)
Changed in 1979 (TRS 641)
Changed in 1982 (TRS 685)
Changed in 1987 (TRS 770)
Changed in 2007 (TRS 950)
Changed in 2021 (TRS 1035)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
Medicines within the same pharmacological class can be used
Therapeutic alternatives limitations
Therapeutic alternatives to be reviewed (2023)
Therapeutic alternatives limitations for EMLc
Therapeutic alternatives to be reviewed (2023)
Patent information
Patents have expired in most jurisdictions
Wikipedia
Warfarin
DrugBank
Warfarin
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended the therapeutic alternatives for warfarin be reviewed.